Mangoceuticals, Inc. (MGRX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$7.96M
Year ended 2024-12-31
2023-12-31: -$9.19M2024-12-31: -$7.96M-$7.96M
2023-12-31 EBITDA (USD) 2024-12-31
Period endedEBITDAChange YoYSource filing
2024-12-31-$7.96Mn/m2026-04-01, From 2024-01-01
2023-12-31-$9.19Mn/a2025-03-20, From 2023-01-01